ARCHIVES

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

Regulatory Agencies: Health Warnings Sought on Cigars

July 23, 1999

NMP22 Assay More Effective Than Conventional Lab Test

January 27, 2006

In Brief: Friends of Cancer Research Honor Specter; Dole Tapes Announcement For CaP CURE

January 24, 1997

NCI-Approved Clinical Trials

September 29, 2006

In Brief: Susumu Tonegawa To Receive Bristol-Myers Award; Mark Green Named Director Of UCSD Cancer Center

March 7, 1986